Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
暂无分享,去创建一个
R. Califf | Lawrence A Leiter | R. Holman | J. McMurray | G. Tognoni | T. Mazzone | Jie-Lena Sun | E. Standl | F. Martinez | D. Preiss | S. Haffner | L. Thomas | F. Chiang | G. Rutten | G. E. Rutten